Alan Davis - Psychedelic Research and Patient Safety at Ohio State and Ibogaine Potential

Ibogaine research and patient safety take center stage in an interview between Joe Moore and Alan Davis, an Associate Professor at Ohio State University. The conversation focuses on the Iboga Patient Survey, a real-world data initiative intended to track safety and efficacy for people using ibogaine for substance use disorders and mental health challenges. Davis emphasizes the need for rigorous, community-informed research to support ethical progress and potential FDA approval, with particular attention to veterans dealing with trauma. They also discuss practical obstacles in clinical trials, including how to generate trustworthy outcomes from real-world settings, tensions between state and federal regulations, and the growing influence of corporate interests in psychedelic research. The episode highlights ethical transparency, community-academic collaboration, and scientific integrity as the field scales.